NEW YORK (GenomeWeb) – Paul Billings has joined Omicia as chief medical officer and will serve on the company's scientific advisory board. Billings was previously chief medical officer at Thermo Fisher's Life Technologies. Before that, he was founding and acting director and CSO at the Genomic Medicine Institute at El Camino Hospital. He was also previously president, CEO, and director of CELLective Dx, as well as senior vice president and senior geneticist at Laboratory Corporation of America. He is currently a director at Trovagene and CollabRx.